eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search

Open access

without publication fees
4/2024
vol. 26
 
Share:
Send email
Share:
Review paper

Recommendations for dispensing magnesium products in pharmacy practice and primary health care

Piotr Merks
1
,
Urszula Religioni
2
,
Marta Jakubowska
3
,
Sainul Abideen Parakkal
4
,
Suhaj Abdulsalim
5
,
Agnieszka Neumann-Podczaska
6
,
Beata Chełstowska
7
,
Mazhuvanchery Kesavan Unnikrishnan
8
,
Alicja Szatko
9
,
Piotr Glinicki
9
,
Shabeer Ali Thorakkattil
10
,
Zbigniew Doniec
11
,
Regis Vaillancourt
1
,
Dagmara Hering
12

  1. Department of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszynski University, Warsaw, Poland
  2. School of Public Health, Centre of Postgraduate Medical Education, Warsaw, Poland
  3. Hospital Pharmacy, Loyds Pharmacy, London, United Kingdom
  4. Clinical Pharmacist, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia
  5. Department of Pharmacy Practice, Unaizah College of Pharmacy, Qassim University, Buraydah, Saudi Arabia
  6. Department of Palliative Medicine, Poznan University of Medical Sciences, Poznan, Poland
  7. Department of Biochemistry and Laboratory Diagnostics, Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszynski University in Warsaw, Poland
  8. Department of Pharmacy Practice, Nitte Gulabi Shetty Memorial Institute of Pharmaceutical Sciences, Mangalore, India
  9. Department of Endocrinology, Centre of Postgraduate Medical Education, Warsaw, Poland
  10. Clinical Pharmacist,, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia
  11. Pneumonology Clinic, Institute of Tuberculosis and Lung Diseases in Rabka-Zdroj, Poland
  12. Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland
Family Medicine & Primary Care Review 2024; 26(4): 538–548
DOI: https://doi.org/10.5114/fmpcr.2024.144926
Online publish date: 2024/12/29
Article file
- 17 FM&PCR 4 24 - R - Merks - 1477 - Recommendations.pdf  [2.08 MB]
Get citation
 
PlumX metrics:
 
1. Kolte D, Vijayaraghavan K, Khera S, et al. WH. Role of magnesium in cardiovascular diseases. Cardiol Rev 2014; 22(4): 182–192.
2. Kirkland AE, Sarlo GL, Holton KF. The Role of Magnesium in Neurological Disorders. Nutrients 2018; 10(6): 730. 
3. Rodríguez-Morán M, Simental Mendía LE, Zambrano Galván G, et al. The role of magnesium in type 2 diabetes: a brief based-clinical review. Magnes Res 2011; 24(4): 156–162.
4. Boulis M, Boulis M, Clauw D. Magnesium and Fibromyalgia: A Literature Review. J Prim Care Community Health 2021; 12: 21501327211038433.
5. ter Borg S, Verlaan S, Hemsworth J, et al. Micronutrient intakes and potential inadequacies of community-dwelling older adults: a systematic review. Br J Nutr 2015; 113(8): 1195–1206. 
6. Rosanoff A, Weaver CM, Rude RK. Suboptimal magnesium status in the United States: are the health consequences underestimated? Nutr Rev 2012; 70(3): 153–164.
7. DiNicolantonio JJ, O’Keefe JH, Wilson W. Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis. Open Heart 2018; 5(1): e000668.
8. Boyle NB, Lawton C, Dye L. The Effects of Magnesium Supplementation on Subjective Anxiety and Stress – A Systematic Review. Nutrients 2017; 9(5): 429. 
9. Karmańska A, Stańczak A, Karwowski B. Magnez – aktualny stan wiedzy. Brom Chem Toksykol 2015: 48(4): 677–689 (in Polish).
10. Schmid P, Rauber D, Betsch C, et al. Barriers of Influenza Vaccination Intention and Behavior – A Systematic Review of Influenza Vaccine Hesitancy, 2005–2016. PLOS ONE 2017; 12: e0170550.
11. Kowalczuk A, Wong A, Chung K, et al. Patient Perceptions on Receiving Vaccination Services through Community Pharmacies. Int J Environ Res Public Health 2022; 19(5): 2538. 
12. Oberska J, Nitsch-Osuch A, Prusaczyk A, et al. Pharmaceutical Care Plus – original scope and significance of pharmaceutical services in primary health care. Fam Med Prim Care Rev 2022; 24(3): 254–257.
13. Porwal M, Singh L, Kumar A, et al. A newly developed assessment tool on collaborative role of doctor–pharmacist in patient medication management. Fam Med Prim Care Rev 2016; 18(1): 44–48.
14. Merks P, Religioni U, Bilmin K, et al. Readiness and Willingness to Provide Immunization Services after Pilot Vaccination Training: A Survey among Community Pharmacists Trained and Not Trained in Immunization during the COVID-19 Pandemic in Poland. Int J Environ Res Public Health 2021; 18(2): 599. 
15. Zheltova AA, Kharitonova MV, Iezhitsa IN, et al. Magnesium deficiency and oxidative stress: an update. Biomedicine (Taipei) 2016; 6(4): 20.
16. Gröber U. Magnesium and drugs. Int J Mol Sci 2019; 20(9): 2094.
17. Orlova S, Dikke G, Pickering G, et al. Risk factors and comorbidities associated with magnesium deficiency in pregnant women and women with hormone-related conditions: analysis of a large real-world dataset. BMC Pregnancy Childbirth 2021; 21(1): 76. 
18. Rylander R. Bioavailability of magnesium salts – a review. J Pharm Nutr Sci 2014; 4(1): 57–59.
19. Noori N, Nafar M, Poorrezagholi F, et al. Dietary intakes of fiber and magnesium and incidence of metabolic syndrome in first year after renal transplantation. J Ren Nutr 2010; 20(2): 101–111.
20. Happy Ch, Lynrah KG. Association of serum magnesium deficiency with insulin resistance in type 2 diabetes mellitus. J Lab Physicians 2015; 7: 75–78.
21. Feng J, Wang H, Jing Z, et al. Role of Magnesium in Type 2 Diabetes Mellitus. Biol Trace Elem Res 2020; 196(1): 74–85.
22. Ref Saris NE, Mervaala E, Karppanen H, et al. Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta 2000; 294: 1–26.
23. de Baaij JH, Hoenderop JG, Bindels RJ. Magnesium in man: implications for health and disease. Physiol Rev 2015; 95(1): 1–46
24. Rude RK. Magnesium. In: Ross AC, Caballero B, Cousins RJ, et al., eds. Modern Nutrition in Health and Disease. 11th ed. Baltimore, Mass: Lippincott Williams & Wilkins; 2012: 159–157.
25. Barbagallo M, Veronese N, Dominguez LJ. Magnesium in Aging, Health and Diseases. Nutrients 2021; 13(2): 463. 
26. Barbagallo M, Dominguez LJ. Magnesium and type 2 diabetes. World J Diabetes 2015; 6(10): 1152–1157.
27. Arpaci D, Tocoglu AG, Ergenc H, et al. Associations of serum Magnesium levels with diabetes mellitus and diabetic complications. Hippokratia 2015; 19(2): 153–157. 
28. Shi Z, Abou-Samra AB. Association of low serum magnesium with diabetes and hypertension: Findings from Qatar Biobank study. Diabetes Res Clin Pract 2019; 158: 107903.
29. Solati M, Ouspid E, Hosseini S, et al. Oral magnesium supplementation in type II diabetic patients. Med J Islam Repub Iran 2014; 28: 67. 
30. Ehrlich B, Barbagallo M, Classen HG, et al. Signicance of magnesium in insulin resistance, metabolic syndrome, and diabetes – recommendations of the Association of Magnesium Research e.V. Trace Elements and Electrolytes 2017; 34, doi: 10.5414/TEX01473.
31. Simental-Mendía LE, Sahebkar A, Rodríguez-Morán M, et al. A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control. Pharmacol Res 2016; 111: 272–282.
32. Verma H, Garg R. Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta-analysis. J Hum Nutr Diet 2017; 30(5): 621–633.
33. Hamedifard Z, Farrokhian A, Reiner Ž, et al. The effects of combined magnesium and zinc supplementation on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease. Lipids Health Dis 2020; 19(1): 112.
34. Kikuchi K, Tanaka H, Gima M, et al. Abnormalities of magnesium (Mg) metabolism and therapeutic signicance of Mg administration in patients with metabolic syndrome, type 2 diabetes, heart failure and chronic hemodialysis. Clinical Calcium 2012; 22(8): 1217–1226.
35. Woldeamanuel YW, Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: A systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci 2017; 372: 307–315.
36. Nattagh-Eshtivani E, Sani MA, Dahri M, et al. The role of nutrients in the pathogenesis and treatment of migraine headaches: Review. Biomed Pharmacother 2018; 102: 317–325.
37. Dolati S, Rikhtegar R, Mehdizadeh A, et al. The Role of Magnesium in Pathophysiology and Migraine Treatment. Biol Trace Elem Res 2020; 196(2): 375–383.
38. Jędrzejek M, Mastalerz-Migas A, Bieńkowski P, et al. Stosowanie preparatów magnezu w praktyce lekarza rodzinnego. Lekarz POZ 2021; 7(2): 141–150 (in Polish).
39. Chiu HY, Yeh TH, Huang YC, et al. Effects of Intravenous and Oral Magnesium on Reducing Migraine: A Meta-analysis of Randomized Controlled Trials. Pain Physician 2016; 19(1): E97–E112. 
40. Gaul C, Diener HC, Danesch U. Migravent® Study Group. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial. J Headache Pain 2015; 16: 516.
41. Köseoglu E, Talaslioglu A, Gönül AS, et al. The effects of magnesium prophylaxis in migraine without aura. Magnes Res 2008; 21(2): 101–108.
42. von Luckner A, Riederer F. Magnesium in Migraine Prophylaxis – Is There an Evidence-Based Rationale? A Systematic Review. Headache 2018; 58(2): 199–209. 
43. Sluka KA, Clauw DJ. Neurobiology of fibromyalgia and chronic widespread pain. Neuroscience 2016; 338: 114–129.
44. Pagliai G, Giangrandi I, Dinu M, et al. Nutritional Interventions in the Management of Fibromyalgia Syndrome. Nutrients 2020; 12(9): 2525.
45. Bjørklund G, Dadar M, Chirumbolo S, et al. Fibromyalgia and nutrition: therapeutic possibilities? Biomed Pharmacother 2018; 103: 531–538.
46. Bagis S, Karabiber M, As I, et al. Is magnesium citrate treatment effective on pain, clinical parameters and functional status in patients with fibromyalgia? Rheumatol Int 2013; 33(1): 167–172. 
47. Andretta A, Dias Batista E, Madalozzo Schieferdecker ME, et al. Relation between magnesium and calcium and parameters of pain, quality of life and depression in women with fibromyalgia. Adv Rheumatol 2019; 59(1): 55. 
48. Martínez-Rodríguez A, Rubio-Arias JÁ, Ramos-Campo DJ, et al. Psychological and sleep effects of tryptophan and magnesium-enriched mediterranean diet in women with fibromyalgia. Int J Environ Res Public Health 2020; 17(7): 2227.
49. Li B, Lv J, Wang W, et al. Dietary magnesium and calcium intake and risk of depression in the general population: A meta-analysis. Aust N Z J Psychiatry 2017; 51(3): 219–229. 
50. Murck H. Magnesium and affective disorders. Nutr Neurosci 2002; 5: 375–389.
51. Derom ML, Sayón-Orea C, Martínez-Ortega JM, et al. Magnesium and depression: a systematic review. Nutr Neurosci 2013; 16(5): 191–206.
52. Nechifor M. Magnesium in major depression. Magnes Res 2009; 22(3): 163S–166S.
53. Jacka FN, Overland S, Stewart R, et al. Association between magnesium intake and depression and anxiety in community-dwelling adults: the Hordaland Health Study. Aust N Z J Psychiatry 2009; 43(1): 45–52.
54. Pickering G, Mazur A, Trousselard M, et al. Magnesium status and stress: the vicious circle concept revisited. Nutrients 2020; 12: 3672.
55. Eby GA, Eby KL. Rapid recovery from major depression using magnesium treatment. Med Hypotheses 2006; 67: 362–370.
56. Barragán-Rodríguez L, Rodríguez-Morán M, Guerrero-Romero F. Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial. Magnes Res 2008; 21(4): 218–223.
57. De Souza MC, Walker AF, Robinson PA, et al. A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study. J Womens Health Gend Based Med 2000; 9(2): 131–139.
58. Tarleton EK, Littenberg B, MacLean CD, et al. Role of magnesium supplementation in the treatment of depression: A randomized clinical trial. PLOS ONE 2017; 12(6): e0180067.
59. Iskra M, Krasińska B, Tykarski A. Magnez – rola fizjologiczna, znaczenie kliniczne niedoboru w nadciśnieniu tętniczym i jego powikłaniach oraz możliwości uzupełniania w organizmie człowieka. Arterial Hypertension 2013; 17(6): 447–459 (in Polish).
60. Zhang X, Li Y, Del Gobbo LC, et al. Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials. Hypertension 2016; 68(2): 324–333.
61. Efstratiadis G, Sarigianni M, Gougourelas I. Hypomagnesemia and cardiovascular system. Hippokratia 2006; 10(4): 147–152.
62. Ma J, Folsom AR, Melnick SL, et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol 1995; 48(7): 927–940.
63. Gröber U, Schmidt J, Kisters K. Magnesium in Prevention and Therapy. Nutrients 2015; 7(9): 8199–8226.
64. Dominguez L, Veronese N, Barbagallo M. Magnesium and Hypertension in Old Age. Nutrients 2020; 13(1): 139.
65. Guerrero-Romero F, Rodríguez-Morán M. The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial. J Hum Hypertens 2009; 23: 245–251.
66. Del Gobbo LC, Imamura F, Wu JH, et al. Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr 2013; 98: 160–173.
67. Kass L, Weekes J, Carpenter L. Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur J Clin Nutr 2012; 66(4): 411–418.
68. Han H, Fang X, Wei X, et al. Dose-response relationship between dietary magnesium intake, serum magnesium concentration, and risk of hypertension: a systematic review and meta-analysis of prospective cohort studies. Nutr J 2017; 16(1): 26.
69. Qu X, Jin F, Hao Y, et al. Magnesium and the risk of cardiovascular events: a meta-analysis of prospective cohort studies. PLOS ONE 2013; 8(3): e57720.
70. Kupetsky-Rincon EA, Uitto J. Magnesium: novel applications in cardiovascular disease-a review of the literature. Ann Nutr Metab 2012; 61(2): 102–110.
71. Song Y, Sesso HD, Manson JE, et al. Dietary magnesium intake and risk of incident hypertension among middle-aged and older US women in a 10-year follow-up study. Am J Cardiol 2006; 98(12): 1616–1621.
Copyright: © 2024 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2025 Termedia Sp. z o.o.
Developed by Bentus.